Goel Mahesh C, Modlin Charles S, Mottoo Araki M, Derweesh Ithaar H, Flechner Stuart M, Streem Steven, Gill Inderbir, Goldfarb David A, Novick Andrew C
Section of Renal Transplant and Minimally Invasive Surgery, Glickman Urological Institute, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA.
J Urol. 2004 Dec;172(6 Pt 1):2326-30. doi: 10.1097/01.ju.0000144716.30222.12.
Laparoscopic donor nephrectomy (LDN) is an increasingly accepted modality for procuring donor kidneys for transplantation. We analyzed and compared the short and long-term outcomes of living transplant allografts from kidneys procured by laparoscopic or open donor (ODN) technique and managed with a single immunosuppression regimen in each group.
Records of recipients who underwent living (laparoscopic or open) donor nephrectomy were reviewed from August 1999 to July 2001 for LDN and from January 1994 to December 1999 for ODN. Patients included were on a single immunosuppression regimen particular to each group. Sirolimus, mycophenolate mofetil and prednisone were given to the LDN group, and calcineurin inhibitor (FK-506 or cyclosporine), mycophenolate mofetil and prednisone were given to the ODN group. Excluded from study were patients with prior kidney transplant or patients not receiving immunosuppression as previously described. Also excluded from study were patients lost to followup before 1 year. Data were retrieved retrospectively from case notes or from the transplant database and analyzed using SAS software (SAS Institute, Cary, North Carolina).
A total of 71 patients from the LDN group and 60 patients from the ODN group qualified for the study. Demographic data are comparable in both groups except for the significantly longer followup in the ODN group. Serum creatinine was 2.2 and 1.8 mg/dl at postoperative day 4, 1.3 and 1.3 mg/dl at day 10, and 1.3 and 1.4 mg/dl at 1 month in the LDN and ODN groups, respectively. Time to achieve nadir serum creatinine was 8.7 versus 6.6 days for LDN and ODN groups, respectively (p = not significant). Delayed graft function was noted in 5 of 71 (7%) in the LDN group and 3 of 60 (5%) in the ODN group (p = 0.5). In the LDN group 13 (18%) patients had a serum creatinine of greater than 1.5 mg/dl at postoperative day 30 compared to 6 (10%) in the ODN group (p = 0.06). Mean serum creatinine at 1 year was lower for LDN recipients (p = not significant). But at last followup this difference became statistically significant in favor of LDN. Mean followup was 939 versus 2,046 days for LDN versus ODN, respectively (p <0.0001). Recipient mean hospital stay was 5.2 versus 6.7 days for LDN versus ODN, respectively (p = 0.08). There were 8 of 78 (10.2%) episodes of acute rejection in the LDN group compared to 22% in the ODN group (p = 0.08). The complication rate (ureteral vascular, lymphocele, acute rejection and wound) was 11% in LDN compared to 15% in the ODN group. Long-term graft function, graft survival and patient survival in the LDN group were comparable to the ODN group.
Early graft recovery is slower in LDN allografts, although not statistically significant, but long-term function in the LDN group is significantly better compared to the ODN group. Laparoscopic donor kidneys take longer to achieve nadir serum creatinine, but this does not influence long-term outcome and results.
腹腔镜供肾切除术(LDN)作为获取供肾用于移植的一种方式,越来越被人们所接受。我们分析并比较了通过腹腔镜或开放供肾(ODN)技术获取的供肾进行活体移植同种异体肾移植的短期和长期结果,且每组均采用单一免疫抑制方案进行管理。
回顾性分析1999年8月至2001年7月接受活体(腹腔镜或开放)供肾切除术患者的记录以研究LDN,回顾1994年1月至1999年12月接受ODN患者的记录。纳入的患者采用每组特定的单一免疫抑制方案。LDN组给予西罗莫司、霉酚酸酯和泼尼松,ODN组给予钙调神经磷酸酶抑制剂(FK - 506或环孢素)、霉酚酸酯和泼尼松。排除既往有肾移植史或未接受上述免疫抑制治疗的患者。同时排除随访不足1年失访的患者。数据通过回顾病例记录或移植数据库进行回顾性收集,并使用SAS软件(SAS Institute,北卡罗来纳州卡里)进行分析。
LDN组共有71例患者,ODN组共有60例患者符合研究标准。除ODN组随访时间明显更长外,两组的人口统计学数据具有可比性。LDN组和ODN组术后第4天血清肌酐分别为2.2和1.8mg/dl,第天分别为1.3和1.3mg/dl,1个月时分别为1.3和1.4mg/dl。LDN组和ODN组达到最低血清肌酐水平的时间分别为8.7天和6.6天(p =无统计学意义)。LDN组71例中有5例(7%)出现移植肾功能延迟恢复,ODN组60例中有3例(5%)出现移植肾功能延迟恢复(p = 0.5)。LDN组13例(18%)患者术后30天血清肌酐大于1.5mg/dl,而ODN组为6例(10%)(p = 0.06)。LDN组受者1年时的平均血清肌酐较低(p =无统计学意义)。但在最后一次随访时,这种差异在统计学上有利于LDN,具有显著性。LDN组和ODN组的平均随访时间分别为939天和2046天(p <0.0001)。LDN组和ODN组受者的平均住院时间分别为5.2天和6.7天(p = 0.08)。LDN组78例中有8例(10.2%)发生急性排斥反应,而ODN组为22%(p = 0.08)。LDN组的并发症发生率(输尿管血管、淋巴囊肿、急性排斥反应和伤口)为11%,ODN组为15%。LDN组的长期移植肾功能、移植肾存活率和患者存活率与ODN组相当。
LDN同种异体肾移植的早期移植肾功能恢复较慢,虽然无统计学意义,但LDN组的长期功能明显优于ODN组。腹腔镜供肾达到最低血清肌酐水平所需时间更长,但这并不影响长期结局和结果。